Table of Content

Chapter 1 About the Non-small Cell Lung Cancer Industry
1.1 Industry Definition and Types
1.1.1 Surgery
1.1.2 Radiofrequency ablation (RFA)
1.1.3 Radiation therapy
1.1.1.4 Chemotherapy
1.1.1.5 Targeted therapies
1.1.1.6 Immunotherapy
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape
2.1 Non-small Cell Lung Cancer Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.3 China
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.4 India
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.2 World Non-small Cell Lung Cancer Market by Types
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy
2.3 World Non-small Cell Lung Cancer Market by Applications
2.4 World Non-small Cell Lung Cancer Market Analysis
2.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2013-2017
2.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2013-2017
2.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2013-2017

Chapter 3 World Non-small Cell Lung Cancer Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2017, Through 2023
3.4 Major Revenue (M USD) Market share By Regions in 2017, Through 2023

Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2013-2017
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis

Chapter 5 Company Profiles
5.1 Bristol-Myers Squibb
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 GlaxoSmithKline
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Sanofi
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 ZIOPHARM Oncology
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Alchemia
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Amgen
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Apotex
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 BioMarin Pharmaceutical
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 CellAct Pharma
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Menarini
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Cerulean Pharma
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Cipla
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 Cornerstone Pharmaceuticals
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
5.14 Curis
5.14.1 Company Details (Foundation Year, Employee Strength and etc)
5.14.2 Product Information (Picture, Specifications and Applications)
5.14.3 Revenue (M USD), Price and Operating Profits
5.15 CytRx
5.15.1 Company Details (Foundation Year, Employee Strength and etc)
5.15.2 Product Information (Picture, Specifications and Applications)
5.15.3 Revenue (M USD), Price and Operating Profits
5.16 Eli Lilly
5.16.1 Company Details (Foundation Year, Employee Strength and etc)
5.16.2 Product Information (Picture, Specifications and Applications)
5.16.3 Revenue (M USD), Price and Operating Profits
5.17 Exelixis
5.17.1 Company Details (Foundation Year, Employee Strength and etc)
5.17.2 Product Information (Picture, Specifications and Applications)
5.17.3 Revenue (M USD), Price and Operating Profits
5.18 Fresenius Kabi
5.18.1 Company Details (Foundation Year, Employee Strength and etc)
5.18.2 Product Information (Picture, Specifications and Applications)
5.18.3 Revenue (M USD), Price and Operating Profits
5.19 Genentech
5.19.1 Company Details (Foundation Year, Employee Strength and etc)
5.19.2 Product Information (Picture, Specifications and Applications)
5.19.3 Revenue (M USD), Price and Operating Profits
5.20 Hikma Pharmaceuticals
5.20.1 Company Details (Foundation Year, Employee Strength and etc)
5.20.2 Product Information (Picture, Specifications and Applications)
5.20.3 Revenue (M USD), Price and Operating Profits
5.21 Hospira
5.21.1 Company Details (Foundation Year, Employee Strength and etc)
5.21.2 Product Information (Picture, Specifications and Applications)
5.21.3 Revenue (M USD), Price and Operating Profits
5.22 Intas Pharmaceuticals
5.22.1 Company Details (Foundation Year, Employee Strength and etc)
5.22.2 Product Information (Picture, Specifications and Applications)
5.22.3 Revenue (M USD), Price and Operating Profits
5.23 Karyopharm Therapeutics
5.23.1 Company Details (Foundation Year, Employee Strength and etc)
5.23.2 Product Information (Picture, Specifications and Applications)
5.23.3 Revenue (M USD), Price and Operating Profits
5.24 Kyowa Hakko Kirin
5.24.1 Company Details (Foundation Year, Employee Strength and etc)
5.24.2 Product Information (Picture, Specifications and Applications)
5.24.3 Revenue (M USD), Price and Operating Profits
5.25 Ligand Pharmaceuticals
5.25.1 Company Details (Foundation Year, Employee Strength and etc)
5.25.2 Product Information (Picture, Specifications and Applications)
5.25.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry

Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India

Chapter 9 World Non-small Cell Lung Cancer Market Forecast through 2023
9.1 World Non-small Cell Lung Cancer Demand by Regions Forecast through 2023
9.2 World Non-small Cell Lung Cancer Price(by Regions, Types, Applications)Analysis Forecast through 2023
9.3 World Non-small Cell Lung Cancer Revenue (M USD)(by Regions, Types, Applications) Forecast through 2023
9.4 World Non-small Cell Lung Cancer Market Analysis
9.4.1 World Non-small Cell Lung Cancer Market Revenue and Growth Rate 2013-2017
9.4.2 World Non-small Cell Lung Cancer Market Consumption and Growth rate 2013-2017
9.4.3 World Non-small Cell Lung Cancer Market Price Analysis 2013-2017

Chapter 10 Key success factors and Market Overview

Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Major Production Market share by Players 2017
Table Major Revenue (M USD) Market share by Players 2017
Table Production Market share by Major Regions in 2013-2017
Table Production Market share by Major Regions in 2017-2023
Table Revenue (M USD) Market share by Regions in 2013-2017
Table Revenue (M USD) Market share by Regions in 2017-2023
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2013-2017
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Bristol-Myers Squibb Information List
Figure Non-small Cell Lung CancerNon-small Cell Lung Cancer Picture, Specifications and Applications of Bristol-Myers Squibb
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Bristol-Myers Squibb 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Bristol-Myers Squibb 2017-2017
Table GlaxoSmithKline Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of GlaxoSmithKline
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of GlaxoSmithKline 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of GlaxoSmithKline 2017-2017
Table Sanofi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Sanofi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Sanofi 2017-2017
Table ZIOPHARM Oncology Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of ZIOPHARM Oncology
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of ZIOPHARM Oncology 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of ZIOPHARM Oncology 2017-2017
Table Alchemia Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Alchemia
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Alchemia 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Alchemia 2017-2017
Table Amgen Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Amgen
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Amgen 2017-2017
Table Apotex Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Apotex
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Apotex 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Apotex 2017-2017
Table BioMarin Pharmaceutical Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of BioMarin Pharmaceutical
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of BioMarin Pharmaceutical 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of BioMarin Pharmaceutical 2017-2017
Table CellAct Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CellAct Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CellAct Pharma 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CellAct Pharma 2017-2017
Table Menarini Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Menarini
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Menarini 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Menarini 2017-2017
Table Cerulean Pharma Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cerulean Pharma
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cerulean Pharma 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cerulean Pharma 2017-2017
Table Cipla Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cipla
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cipla 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cipla 2017-2017
Table Cornerstone Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Cornerstone Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cornerstone Pharmaceuticals 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Cornerstone Pharmaceuticals 2017-2017
Table Curis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Curis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Curis 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Curis 2017-2017
Table CytRx Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of CytRx
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CytRx 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of CytRx 2017-2017
Table Eli Lilly Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Eli Lilly
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eli Lilly 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Eli Lilly 2017-2017
Table Exelixis Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Exelixis
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Exelixis 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Exelixis 2017-2017
Table Fresenius Kabi Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Fresenius Kabi
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Fresenius Kabi 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Fresenius Kabi 2017-2017
Table Genentech Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Genentech
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Genentech 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Genentech 2017-2017
Table Hikma Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hikma Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hikma Pharmaceuticals 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hikma Pharmaceuticals 2017-2017
Table Hospira Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Hospira
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Hospira 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Hospira 2017-2017
Table Intas Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Intas Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Intas Pharmaceuticals 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Intas Pharmaceuticals 2017-2017
Table Karyopharm Therapeutics Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Karyopharm Therapeutics
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Karyopharm Therapeutics 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Karyopharm Therapeutics 2017-2017
Table Kyowa Hakko Kirin Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Kyowa Hakko Kirin
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Kyowa Hakko Kirin 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Kyowa Hakko Kirin 2017-2017
Table Ligand Pharmaceuticals Information List
Figure Non-small Cell Lung Cancer Picture, Specifications and Applications of Ligand Pharmaceuticals
Table Non-small Cell Lung Cancer Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Ligand Pharmaceuticals 2017-2017
Figure Non-small Cell Lung Cancer Sales Volume and World Market Share of Ligand Pharmaceuticals 2017-2017
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Price by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Price by Types Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Price by Applications Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Revenue (M USD) by Regions Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Revenue (M USD) by Types Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)
Table World Revenue (M USD) by Applications Forecast Analysis of Non-small Cell Lung Cancer (2017-2023)